|
CC-99282 Clinical Trials
1 actively recruiting trial across 1 location
▼ -1 trial since June 2026
Also known as: BMS-986369
Birmingham, Alabama1 trial
Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma
University Hospital (University Of Alabama Hospital)
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.